|
US2809194A
(en)
*
|
|
1957-10-08 |
|
Thiadiazine type natriuretic agents |
|
US3108097A
(en)
*
|
|
1963-10-22 |
|
Ehnojs |
|
FR1103113A
(fr)
|
1954-04-15 |
1955-10-31 |
|
Triméthylol-alcanes et leur procédé de préparation
|
|
FR1217929A
(fr)
|
1958-03-03 |
1960-05-06 |
Ciba Geigy |
Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels
|
|
BE578515A
(da)
*
|
1958-05-07 |
|
|
|
|
DE1302648B
(da)
|
1960-09-27 |
|
|
|
|
NL127065C
(da)
*
|
1964-04-22 |
|
|
|
|
NL137318C
(da)
*
|
1964-06-09 |
|
|
|
|
GB1415295A
(en)
|
1971-10-14 |
1975-11-26 |
Orchimed Sa |
Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof
|
|
US3716583A
(en)
*
|
1969-04-16 |
1973-02-13 |
Sumitomo Chemical Co |
Phenoxy carboxylic acid derivative
|
|
US3692895A
(en)
*
|
1970-09-08 |
1972-09-19 |
Norman A Nelson |
Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
|
|
DE2046823A1
(de)
|
1970-09-23 |
1972-03-30 |
Farbwerke Hoechst AG vormals Meister Lucius & Brüning, 6000 Frankfurt |
Neue Azetidinone-(2) und Verfahren zu deren Herstellung
|
|
DE2230383C3
(de)
*
|
1971-10-01 |
1981-12-03 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Phenoxyalkylcarbonsäurederivate und Verfahren zur Herstellung derselben
|
|
US4148923A
(en)
*
|
1972-05-31 |
1979-04-10 |
Synthelabo |
1-(3'-Trifluoromethylthiophenyl)-2-ethylaminopropane pharmaceutical composition and method for treating obesity
|
|
US3948973A
(en)
*
|
1972-08-29 |
1976-04-06 |
Sterling Drug Inc. |
Halocyclopropyl substituted phenoxyalkanoic acids
|
|
US4626549A
(en)
*
|
1974-01-10 |
1986-12-02 |
Eli Lilly And Company |
Treatment of obesity with aryloxyphenylpropylamines
|
|
DE2521113A1
(de)
|
1974-05-15 |
1976-03-18 |
Maggioni & C Spa |
Cycloaliphatische derivate von 3.3-diphenylpropylamin
|
|
JPS5195049A
(en)
*
|
1975-02-12 |
1976-08-20 |
|
* **********so*****no***tsu*****************************************ni*no
|
|
US4235896A
(en)
*
|
1975-02-12 |
1980-11-25 |
Orchimed S.A. |
Benzyl-phenoxy acid esters and hyperlipaemia compositions containing the same
|
|
US4179515A
(en)
*
|
1975-02-12 |
1979-12-18 |
Orchimed S. A. |
Benzoylphenoxy propionic acid, esters thereof and pharmaceutical composition
|
|
US4075000A
(en)
*
|
1975-05-27 |
1978-02-21 |
Eli Lilly And Company |
Herbicidal use of 4-amino-3,3-dimethyl-1-phenyl-2-azetidinones
|
|
US4304718A
(en)
*
|
1975-10-06 |
1981-12-08 |
Fujisawa Pharmaceutical Co., Ltd. |
2-Azetidinone compounds and processes for preparation thereof
|
|
US4472309A
(en)
*
|
1975-10-06 |
1984-09-18 |
Fujisawa Pharmaceutical Co., Ltd. |
2-Azetidinone compounds and processes for preparation thereof
|
|
US4576753A
(en)
*
|
1975-10-06 |
1986-03-18 |
Fujisawa Pharmaceutical Co., Ltd. |
Azetidinone compounds and processes for preparation thereof
|
|
US4166907A
(en)
*
|
1976-11-01 |
1979-09-04 |
E. R. Squibb & Sons, Inc. |
3,3-Dichloro-2-azetidinone derivatives having antiinflammatory activity
|
|
US4144232A
(en)
*
|
1976-12-23 |
1979-03-13 |
Eli Lilly And Company |
Substituted azetidin-2-one antibiotics
|
|
FR2403078A1
(fr)
*
|
1977-09-19 |
1979-04-13 |
Lafon Labor |
Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
|
|
IT1157365B
(it)
*
|
1977-10-24 |
1987-02-11 |
Sandoz Ag |
Medicamenti per trattare l'obesita' o ridurre il peso del corpo
|
|
FR2408577A1
(fr)
|
1977-11-14 |
1979-06-08 |
Devinter Sa |
Nouveau procede de synthese d'esters para chlorobenzoyl phenoxy isobutyriques
|
|
NZ191762A
(en)
|
1978-10-19 |
1982-09-14 |
Merck & Co Inc |
Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
|
|
US4250191A
(en)
*
|
1978-11-30 |
1981-02-10 |
Edwards K David |
Preventing renal failure
|
|
US4375475A
(en)
*
|
1979-08-17 |
1983-03-01 |
Merck & Co., Inc. |
Substituted pyranone inhibitors of cholesterol synthesis
|
|
US4260743A
(en)
*
|
1979-12-31 |
1981-04-07 |
Gist-Brocades N.V. |
Preparation of β-lactams and intermediates therefor
|
|
US4444784A
(en)
*
|
1980-08-05 |
1984-04-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
ES8101585A1
(es)
|
1980-02-15 |
1980-12-16 |
Especialidades Farmaco Terape |
Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico
|
|
FR2494112B1
(da)
|
1980-11-19 |
1986-01-10 |
Laruelle Claude |
|
|
DE3107100A1
(de)
*
|
1981-02-20 |
1982-09-09 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Azaprostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
|
US4500456A
(en)
*
|
1981-03-09 |
1985-02-19 |
Eli Lilly And Company |
Preparation of 4-fluoroazetidinones using FClO3
|
|
US4784734A
(en)
*
|
1981-04-10 |
1988-11-15 |
Otsuka Kagaku Yakuhin Kabushiki Kaisha |
Azetidinone derivatives and process for the preparation of the same
|
|
US4602005A
(en)
*
|
1982-05-17 |
1986-07-22 |
Medical Research Foundation Of Oregon |
Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
|
|
US4602003A
(en)
*
|
1982-05-17 |
1986-07-22 |
Medical Research Foundation Of Oregon |
Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
|
|
US4534786A
(en)
*
|
1982-06-23 |
1985-08-13 |
Chevron Research Company |
1-Alkyl derivatives of 3-aryloxy-4-(2-carbalkoxy)-phenyl-azet-2-ones as plant growth regulators
|
|
US4443372A
(en)
*
|
1982-06-23 |
1984-04-17 |
Chevron Research Company |
1-Alkyl derivatives of 3-aryloxy-4-(2-carbalkoxy)-phenyl-azet-2-ones as plant growth regulators
|
|
US4595532A
(en)
*
|
1983-02-02 |
1986-06-17 |
University Of Notre Dame Du Lac |
N-(substituted-methyl)-azetidin-2-ones
|
|
CA1256650A
(en)
*
|
1983-03-25 |
1989-06-27 |
Toshinari Tamura |
Process of producing 2-azetidinone-4-substituted compounds, and medicaments containing the compounds
|
|
US4614614A
(en)
*
|
1983-03-28 |
1986-09-30 |
Ciba-Geigy Corporation |
Process for the manufacture of optically active azetidinones
|
|
US4675399A
(en)
*
|
1983-03-28 |
1987-06-23 |
Notre Dame University |
Cyclization process for β-lactams
|
|
WO1985004876A1
(en)
*
|
1984-04-24 |
1985-11-07 |
Takeda Chemical Industries, Ltd. |
2-azetidinone derivatives and process for their preparation
|
|
US4576749A
(en)
*
|
1983-10-03 |
1986-03-18 |
E. R. Squibb & Sons, Inc. |
3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
|
|
US5229510A
(en)
*
|
1983-12-01 |
1993-07-20 |
Merck & Co., Inc. |
β-lactams useful in determining the amount of elastase in a clinical sample
|
|
US4680391A
(en)
*
|
1983-12-01 |
1987-07-14 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US5229381A
(en)
*
|
1983-12-01 |
1993-07-20 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US4654362A
(en)
*
|
1983-12-05 |
1987-03-31 |
Janssen Pharmaceutica, N.V. |
Derivatives of 2,2'-iminobisethanol
|
|
FR2561916B1
(fr)
*
|
1984-03-30 |
1987-12-11 |
Lafon Labor |
Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
|
|
US4581170A
(en)
*
|
1984-08-03 |
1986-04-08 |
E. R. Squibb & Sons, Inc. |
N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
|
|
US4633017A
(en)
*
|
1984-08-03 |
1986-12-30 |
E. R. Squibb & Sons, Inc. |
N-hydroxy protecting groups and process for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
|
|
US4576748A
(en)
*
|
1984-09-17 |
1986-03-18 |
Merck & Co., Inc. |
3-Hydroxy-3-aminoethyl β-lactams
|
|
US4647576A
(en)
|
1984-09-24 |
1987-03-03 |
Warner-Lambert Company |
Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
|
|
US4620867A
(en)
*
|
1984-09-28 |
1986-11-04 |
Chevron Research Company |
1-carbalkoxyalkyl-3-aryloxy-4-(substituted-2'-carboxyphenyl)-azet-2-ones as plant growth regulators and herbicides
|
|
AR240698A1
(es)
*
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
US4642903A
(en)
*
|
1985-03-26 |
1987-02-17 |
R. P. Scherer Corporation |
Freeze-dried foam dosage form
|
|
US4680289A
(en)
*
|
1985-06-05 |
1987-07-14 |
Progenics, Inc. |
Treatment of obesity and diabetes using sapogenins
|
|
JPH0679559B2
(ja)
|
1985-06-06 |
1994-10-12 |
三共株式会社 |
光学活性アゼチジノン誘導体の製法
|
|
WO1987004429A1
(en)
|
1986-01-23 |
1987-07-30 |
The Upjohn Company |
Antimicrobial n-acyl-2-azetidinones
|
|
EP0234484B1
(en)
*
|
1986-02-19 |
1993-10-20 |
Sanraku Incorporated |
Novel azetidinone derivatives
|
|
GB8607312D0
(en)
*
|
1986-03-25 |
1986-04-30 |
Ici Plc |
Therapeutic agents
|
|
FR2598146B1
(fr)
*
|
1986-04-30 |
1989-01-20 |
Rech Ind |
Nouveau procede de preparation de fibrates.
|
|
DE3621861A1
(de)
*
|
1986-06-30 |
1988-01-14 |
Laszlo Dr Med Ilg |
Verwendung von aryloxycarbonsaeure-derivaten gegen dermatologische erkrankungen
|
|
JPS6317859A
(ja)
|
1986-07-11 |
1988-01-25 |
Sagami Chem Res Center |
フルオロアゼチジノン誘導体
|
|
FR2602423B1
(fr)
*
|
1986-08-08 |
1989-05-05 |
Ethypharm Sa |
Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
|
|
US4814354A
(en)
*
|
1986-09-26 |
1989-03-21 |
Warner-Lambert Company |
Lipid regulating agents
|
|
DE3780909T2
(de)
|
1986-10-03 |
1993-03-04 |
Lilly Co Eli |
7-((meta-substituiert)-phenylglycin)-1-carba-1-dethia-cephalosporine.
|
|
US4803266A
(en)
*
|
1986-10-17 |
1989-02-07 |
Taisho Pharmaceutical Co., Ltd. |
3-Oxoalkylidene-2-azetidinone derivatives
|
|
AU604806B2
(en)
|
1986-12-15 |
1991-01-03 |
Eli Lilly And Company |
Antibiotic a10255 complex and factors, microorganisms, process and production therefor
|
|
ZA879415B
(en)
|
1986-12-15 |
1989-08-30 |
Lilly Co Eli |
Antibiotic a10255 complex and factors,microorganisms,process and production therefor
|
|
US5229362A
(en)
*
|
1986-12-15 |
1993-07-20 |
Eli Lilly And Company |
Antibiotic A10255 complex and factors, and process and production therefor
|
|
JPS63156788A
(ja)
|
1986-12-22 |
1988-06-29 |
Sanraku Inc |
光学活性アゼチジノン類
|
|
EP0276807A3
(en)
|
1987-01-27 |
1988-10-12 |
Warner-Lambert Company |
Lipid regulating compositions
|
|
US5110730A
(en)
*
|
1987-03-31 |
1992-05-05 |
The Scripps Research Institute |
Human tissue factor related DNA segments
|
|
DE3877406T2
(de)
*
|
1987-04-28 |
1993-06-09 |
Fujisawa Astra Ltd |
Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
|
|
US5106833A
(en)
*
|
1987-07-23 |
1992-04-21 |
Washington University |
Coagulation inhibitors
|
|
DD273634A5
(de)
|
1987-10-06 |
1989-11-22 |
����@�����@�����@����k�� |
Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins
|
|
US5091525A
(en)
*
|
1987-10-07 |
1992-02-25 |
Eli Lilly And Company |
Monohydrate and DMF solvates of a new carbacephem antibiotic
|
|
US4834846A
(en)
*
|
1987-12-07 |
1989-05-30 |
Merck & Co., Inc. |
Process for deblocking N-substituted β-lactams
|
|
US5385885A
(en)
|
1988-01-15 |
1995-01-31 |
Gasic; Gregory P. |
Inhibition of smooth muscle cell proliferation by antistasin and tick anticoagulant peptide
|
|
FR2627696B1
(fr)
*
|
1988-02-26 |
1991-09-13 |
Fournier Innovation Synergie |
Nouvelle forme galenique du fenofibrate
|
|
DE3807895A1
(de)
*
|
1988-03-10 |
1989-09-21 |
Knoll Ag |
Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
|
|
EP0333268A1
(en)
|
1988-03-18 |
1989-09-20 |
Merck & Co. Inc. |
Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
|
|
NZ228600A
(en)
|
1988-04-11 |
1992-02-25 |
Merck & Co Inc |
1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives
|
|
GB8813012D0
(en)
*
|
1988-06-02 |
1988-07-06 |
Norsk Hydro As |
Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals
|
|
FR2634376B1
(fr)
|
1988-07-21 |
1992-04-17 |
Farmalyoc |
Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
|
|
US4952689A
(en)
|
1988-10-20 |
1990-08-28 |
Taisho Pharmaceutical Co., Ltd. |
3-(substituted propylidene)-2-azetidinone derivates for blood platelet aggregation
|
|
CA2002596A1
(en)
|
1988-11-14 |
1990-05-14 |
Thomas M. Eckrich |
Hydrates of b-lactam antibiotic
|
|
CA1340977C
(en)
|
1988-11-15 |
2000-04-25 |
Monty Krieger |
Scavenger receptor protein and antibody thereto
|
|
US5112616A
(en)
*
|
1988-11-30 |
1992-05-12 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US5073374A
(en)
*
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US4876365A
(en)
*
|
1988-12-05 |
1989-10-24 |
Schering Corporation |
Intermediate compounds for preparing penems and carbapenems
|
|
US5260305A
(en)
*
|
1988-12-12 |
1993-11-09 |
E. R. Squibb & Sons, Inc. |
Combination of pravastatin and nicotinic acid or related acid and method for lowering serum cholesterol using such combination
|
|
FR2640621B1
(fr)
|
1988-12-19 |
1992-10-30 |
Centre Nat Rech Scient |
N-aryl-azetidinones, leur procede de preparation et leur utilisation comme inhibiteurs des elastases
|
|
US4990535A
(en)
*
|
1989-05-03 |
1991-02-05 |
Schering Corporation |
Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
|
|
AU628549B2
(en)
*
|
1989-05-12 |
1992-09-17 |
De Beers Industrial Diamond Division (Proprietary) Limited |
Wire drawing die
|
|
CA2016467A1
(en)
|
1989-06-05 |
1990-12-05 |
Martin Eisman |
Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
|
|
JPH03108490A
(ja)
*
|
1989-06-30 |
1991-05-08 |
Shionogi & Co Ltd |
フォスフォリパーゼａ↓２阻害物質
|
|
US5021461A
(en)
*
|
1989-07-26 |
1991-06-04 |
Merrell Dow Pharmaceuticals Inc. |
Method of treating diabetes mellitus with bisphenol derivatives
|
|
US4983597A
(en)
*
|
1989-08-31 |
1991-01-08 |
Merck & Co., Inc. |
Beta-lactams as anticholesterolemic agents
|
|
IL95574A
(en)
|
1989-09-09 |
1994-11-11 |
Knoll Ag |
Colestyramine preparation
|
|
US5219574A
(en)
*
|
1989-09-15 |
1993-06-15 |
Cima Labs. Inc. |
Magnesium carbonate and oil tableting aid and flavoring additive
|
|
US5223264A
(en)
*
|
1989-10-02 |
1993-06-29 |
Cima Labs, Inc. |
Pediatric effervescent dosage form
|
|
US5178878A
(en)
*
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
|
US5188825A
(en)
*
|
1989-12-28 |
1993-02-23 |
Iles Martin C |
Freeze-dried dosage forms and methods for preparing the same
|
|
ATE108797T1
(de)
*
|
1990-04-13 |
1994-08-15 |
Pfizer |
Verfahren für sultamicillinzwischenprodukt.
|
|
CA2039763A1
(en)
|
1990-04-30 |
1991-10-31 |
Henry Y. Pan |
Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
|
|
CA2040865C
(en)
|
1990-05-15 |
2002-07-23 |
James L. Bergey |
Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
|
|
US5298497A
(en)
|
1990-05-15 |
1994-03-29 |
E. R. Squibb & Sons, Inc. |
Method for preventing onset of hypertension employing a cholesterol lowering drug
|
|
US5622985A
(en)
|
1990-06-11 |
1997-04-22 |
Bristol-Myers Squibb Company |
Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
|
|
CA2042526A1
(en)
|
1990-06-11 |
1991-12-12 |
Adeoye Y. Olukotun |
Method for preventing a second heart attack employing an hmg coa reductase inhibitor
|
|
US5120729A
(en)
*
|
1990-06-20 |
1992-06-09 |
Merck & Co., Inc. |
Beta-lactams as antihypercholesterolemics
|
|
CA2048395A1
(en)
|
1990-08-23 |
1992-02-24 |
Henry Y. Pan |
Method for preventing onset of or treating type iii hyperlipoproteinemia employing pravastatin
|
|
US5120713A
(en)
*
|
1990-09-10 |
1992-06-09 |
Applied Research Systems Ars Holding N.V. |
Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
|
|
US5075313A
(en)
|
1990-09-13 |
1991-12-24 |
Eli Lilly And Company |
3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof
|
|
IL99658A0
(en)
|
1990-10-15 |
1992-08-18 |
Merck & Co Inc |
Substituted azetidinones and pharmaceutical compositions containing them
|
|
CA2052014A1
(en)
|
1990-10-19 |
1992-04-20 |
Henry Y. Pan |
Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
|
|
US5190970A
(en)
*
|
1990-10-19 |
1993-03-02 |
E. R. Squibb & Sons, Inc. |
Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
|
|
US5130333A
(en)
*
|
1990-10-19 |
1992-07-14 |
E. R. Squibb & Sons, Inc. |
Method for treating type II diabetes employing a cholesterol lowering drug
|
|
JP2640986B2
(ja)
*
|
1990-11-08 |
1997-08-13 |
高砂香料工業株式会社 |
（１′ｒ，３ｓ）―３―（１′―ヒドロキシエチル）―アゼチジン―２―オン又はその誘導体の製造法
|
|
IL100091A
(en)
|
1990-12-12 |
1998-08-16 |
Zeneca Ltd |
Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5145684A
(en)
*
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
AU642066B2
(en)
|
1991-01-25 |
1993-10-07 |
Nanosystems L.L.C. |
X-ray contrast compositions useful in medical imaging
|
|
US5552160A
(en)
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
|
IT1244699B
(it)
|
1991-02-01 |
1994-08-08 |
Luso Farmaco Inst |
Processo per la preparazione di acidi 3 acilammino-4- carbamoilossimetil-2-azetidinone-l-solfonici ed intermedi per la loro preparazione
|
|
US5157025A
(en)
*
|
1991-04-01 |
1992-10-20 |
E. R. Squibb & Sons, Inc. |
Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
|
|
US5348953A
(en)
|
1991-06-25 |
1994-09-20 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US5464632C1
(en)
|
1991-07-22 |
2001-02-20 |
Prographarm Lab |
Rapidly disintegratable multiparticular tablet
|
|
US5561227A
(en)
|
1991-07-23 |
1996-10-01 |
Schering Corporation |
Process for the stereospecific synthesis of azetidinones
|
|
DE69222532T2
(de)
*
|
1991-07-23 |
1998-02-26 |
Schering Corp |
Substituierte beta-lactam-verbindungen als hypocholesterolemische mittel und verfahren zu deren herstellung
|
|
US5688785A
(en)
|
1991-07-23 |
1997-11-18 |
Schering Corporation |
Substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5688787A
(en)
|
1991-07-23 |
1997-11-18 |
Schering Corporation |
Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof
|
|
JP2620437B2
(ja)
|
1991-09-27 |
1997-06-11 |
宇部興産株式会社 |
ω−ヒドロキシ−（ω−３）−ケトニトリルおよびω−ヒドロキシ脂肪酸の製法
|
|
ES2114948T3
(es)
|
1991-10-04 |
1998-06-16 |
Procter & Gamble |
Compuestos disminuidores del colesterol y procedimiento para prepararlos.
|
|
US5162117A
(en)
*
|
1991-11-22 |
1992-11-10 |
Schering Corporation |
Controlled release flutamide composition
|
|
FI942394A0
(fi)
|
1991-11-25 |
1994-05-24 |
Pfizer |
Menetelmä steroidiperasyyliglykosidien valmistamiseksi
|
|
DE4203932A1
(de)
|
1992-02-11 |
1993-08-12 |
Deutsche Aerospace |
Sende-/empfangsmodul
|
|
US6063764A
(en)
|
1992-06-01 |
2000-05-16 |
Washington University & Chiron Corp. |
Method for using lipoprotein associated coagulation inhibitor to treat sepsis
|
|
JPH07504921A
(ja)
|
1992-06-26 |
1995-06-01 |
フアイザー・インコーポレイテツド |
高コレステロール血症を治療するためのステロイドグリコシド
|
|
US5278176A
(en)
*
|
1992-08-21 |
1994-01-11 |
Abbott Laboratories |
Nicotine derivatives that enhance cognitive function
|
|
CA2147129A1
(en)
|
1992-10-27 |
1994-05-11 |
James B. Doherty |
New substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US5631363A
(en)
|
1992-11-13 |
1997-05-20 |
Tanabe Seiyaku Co., Ltd. |
Azetidinone compound and process for preparation thereof
|
|
NZ248813A
(en)
|
1992-11-25 |
1995-06-27 |
Eastman Kodak Co |
Polymeric grinding media used in grinding pharmaceutical substances
|
|
WO1994020535A1
(en)
|
1992-12-11 |
1994-09-15 |
Corvas International, Inc. |
ECOTIN AS A FACTOR Xa, XIa, AND XIIa INHIBITOR
|
|
US5429824A
(en)
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
|
US5358852A
(en)
|
1992-12-21 |
1994-10-25 |
Eastman Kodak Company |
Use of calcium in immunoassay for measurement of C-reactive protein
|
|
LT3300B
(en)
|
1992-12-23 |
1995-06-26 |
Schering Corp |
Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
|
|
LT3595B
(en)
*
|
1993-01-21 |
1995-12-27 |
Schering Corp |
Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
|
|
US5563264A
(en)
|
1993-02-10 |
1996-10-08 |
Shionogi & Co., Ltd. |
Preparation of βlactam compounds
|
|
US5503846A
(en)
|
1993-03-17 |
1996-04-02 |
Cima Labs, Inc. |
Base coated acid particles and effervescent formulation incorporating same
|
|
US5412092A
(en)
|
1993-04-23 |
1995-05-02 |
Bristol-Myers Squibb Company |
N-substituted 2-azetidinones
|
|
IL109568A0
(en)
|
1993-05-19 |
1994-08-26 |
Fujisawa Pharmaceutical Co |
Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
|
|
US5703188A
(en)
|
1993-06-02 |
1997-12-30 |
Geltex Pharmaceuticals, Inc. |
Process for removing bile salts from a patient and compositions therefor
|
|
US5550229A
(en)
|
1993-06-23 |
1996-08-27 |
Tanabe Seiyaku Co., Ltd. |
Alkylation process for preparing azetidinone compound and starting compound therefor
|
|
JP2840452B2
(ja)
|
1993-07-09 |
1998-12-24 |
シェリング・コーポレーション |
アゼチジノンの合成方法
|
|
US5631023A
(en)
|
1993-07-09 |
1997-05-20 |
R.P. Scherer Corporation |
Method for making freeze dried drug dosage forms
|
|
AU7376494A
(en)
|
1993-08-04 |
1995-02-28 |
Andrulis Pharmaceuticals Corporation |
Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents
|
|
AU7397094A
(en)
|
1993-08-30 |
1995-03-22 |
Merck & Co., Inc. |
Prevention and treatment of alzheimer's disease
|
|
US5622719A
(en)
|
1993-09-10 |
1997-04-22 |
Fuisz Technologies Ltd. |
Process and apparatus for making rapidly dissolving dosage units and product therefrom
|
|
US5895664A
(en)
|
1993-09-10 |
1999-04-20 |
Fuisz Technologies Ltd. |
Process for forming quickly dispersing comestible unit and product therefrom
|
|
US5851553A
(en)
|
1993-09-10 |
1998-12-22 |
Fuisz Technologies, Ltd. |
Process and apparatus for making rapidly dissolving dosage units and product therefrom
|
|
US5631365A
(en)
|
1993-09-21 |
1997-05-20 |
Schering Corporation |
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5976570A
(en)
|
1993-12-21 |
1999-11-02 |
Applied Analytical Industries, Inc. |
Method for preparing low dose pharmaceutical products
|
|
CA2180148A1
(en)
|
1993-12-28 |
1995-07-06 |
Michael Paul Deninno |
Hypocholesterolemic agents
|
|
US6369103B1
(en)
|
1994-01-18 |
2002-04-09 |
Bristol-Myers Squibb Company |
Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
|
|
US5595761A
(en)
|
1994-01-27 |
1997-01-21 |
The Board Of Regents Of The University Of Oklahoma |
Particulate support matrix for making a rapidly dissolving tablet
|
|
US5576014A
(en)
|
1994-01-31 |
1996-11-19 |
Yamanouchi Pharmaceutical Co., Ltd |
Intrabuccally dissolving compressed moldings and production process thereof
|
|
GB9401892D0
(en)
|
1994-02-01 |
1994-03-30 |
Boots Co Plc |
Therapeutic agents
|
|
US5635210A
(en)
|
1994-02-03 |
1997-06-03 |
The Board Of Regents Of The University Of Oklahoma |
Method of making a rapidly dissolving tablet
|
|
US5627176A
(en)
|
1994-03-25 |
1997-05-06 |
Schering Corporation |
Substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
GB9406074D0
(en)
|
1994-03-26 |
1994-05-18 |
Glaxo Spa |
Chemical process
|
|
DE4414538A1
(de)
|
1994-04-26 |
1995-11-02 |
Klinge Co Chem Pharm Fab |
Präparate zur Therapie der kombinierten Hyperlipidämie mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem Fibrat
|
|
US5554746A
(en)
|
1994-05-16 |
1996-09-10 |
Isis Pharmaceuticals, Inc. |
Lactam nucleic acids
|
|
TW384224B
(en)
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
|
US5718388A
(en)
|
1994-05-25 |
1998-02-17 |
Eastman Kodak |
Continuous method of grinding pharmaceutical substances
|
|
US5567439A
(en)
|
1994-06-14 |
1996-10-22 |
Fuisz Technologies Ltd. |
Delivery of controlled-release systems(s)
|
|
EP0766667A1
(en)
|
1994-06-20 |
1997-04-09 |
Schering Corporation |
Substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US6429289B1
(en)
|
1994-06-23 |
2002-08-06 |
Massachusetts Institute Of Technology |
Class BI and CI scavenger receptors
|
|
JPH09511753A
(ja)
|
1994-09-20 |
1997-11-25 |
ファイザー・インコーポレーテッド |
コレステロール吸収阻害薬とコレステロール合成阻害薬の併用
|
|
GB9421836D0
(en)
|
1994-10-28 |
1994-12-14 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
|
|
GB9421816D0
(en)
|
1994-10-29 |
1994-12-14 |
Smithkline Beecham Plc |
Novel compounds
|
|
US5624920A
(en)
|
1994-11-18 |
1997-04-29 |
Schering Corporation |
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5633246A
(en)
*
|
1994-11-18 |
1997-05-27 |
Schering Corporation |
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5656624A
(en)
*
|
1994-12-21 |
1997-08-12 |
Schering Corporation |
4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
|
|
US5990102A
(en)
|
1994-12-22 |
1999-11-23 |
Smithkline Beecham P.L.C. |
Substituted azetidin-2-ones for treatment of atherosclerosis
|
|
US5902726A
(en)
|
1994-12-23 |
1999-05-11 |
Glaxo Wellcome Inc. |
Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
|
|
KR100264348B1
(ko)
|
1994-12-28 |
2000-08-16 |
디르크 반테 |
항-죽종형성제로서 네비볼롤을 함유하는 조성물
|
|
US5545628A
(en)
|
1995-01-10 |
1996-08-13 |
Galephar P.R. Inc. |
Pharmaceutical composition containing fenofibrate
|
|
FR2730231B1
(fr)
|
1995-02-02 |
1997-04-04 |
Fournier Sca Lab |
Association de fenofibrate et de vitamine e, utilisation en therapeutique
|
|
US5639475A
(en)
|
1995-02-03 |
1997-06-17 |
Eurand America, Incorporated |
Effervescent microcapsules
|
|
US5518738A
(en)
|
1995-02-09 |
1996-05-21 |
Nanosystem L.L.C. |
Nanoparticulate nsaid compositions
|
|
US5591456A
(en)
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US5747001A
(en)
|
1995-02-24 |
1998-05-05 |
Nanosystems, L.L.C. |
Aerosols containing beclomethazone nanoparticle dispersions
|
|
US5998441A
(en)
|
1995-02-28 |
1999-12-07 |
Eli Lilly And Company |
Benzothiophene compounds, intermediates, compositions, and methods
|
|
US5639739A
(en)
|
1995-03-24 |
1997-06-17 |
The Dupont Merck Pharmaceutical Company |
Imidazole containing aminoboronic acids
|
|
US5759865A
(en)
|
1995-05-03 |
1998-06-02 |
Eli Lilly And Company |
Combinatorial process for synthesizing azetidinone analogs
|
|
DE19518988A1
(de)
|
1995-05-29 |
1996-12-05 |
Basf Ag |
Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit
|
|
JP3144624B2
(ja)
*
|
1995-06-02 |
2001-03-12 |
杏林製薬株式会社 |
Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
|
|
US5612378A
(en)
|
1995-06-06 |
1997-03-18 |
3-Dimensional Pharmaceuticals, Inc. |
Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors
|
|
US5612353A
(en)
|
1995-06-07 |
1997-03-18 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
|
|
AU6039296A
(en)
|
1995-06-07 |
1996-12-30 |
G.D. Searle & Co. |
Method to treat cardiofibrosis with a combination therapy of an angiotensin ii antagonist and an epoxy-steroidal aldoste rone antagonist
|
|
US5607697A
(en)
|
1995-06-07 |
1997-03-04 |
Cima Labs, Incorporated |
Taste masking microparticles for oral dosage forms
|
|
NZ286920A
(en)
|
1995-07-03 |
1997-06-24 |
Sankyo Co |
Use of combination of hmg-coa reductase inhibitors and of insulin sensitizers for the prevention/treatment of arteriosclerosis or xanthoma
|
|
FR2737121B1
(fr)
|
1995-07-27 |
1997-10-03 |
Cl Pharma |
Nouvelles formulations galeniques du fenofibrate et leurs applications
|
|
US5698527A
(en)
|
1995-08-08 |
1997-12-16 |
Merck & Co., Inc. |
Steroidal glycosides as antihyperlipidemic agents
|
|
FR2738817B1
(fr)
|
1995-09-14 |
1997-10-17 |
Adir |
Nouveaux acides et esters 2,2-dimethyl-omega-phenoxy alcanoiques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5618707A
(en)
|
1996-01-04 |
1997-04-08 |
Schering Corporation |
Stereoselective microbial reduction of 5-fluorophenyl-5-oxo-pentanoic acid and a phenyloxazolidinone condensation product thereof
|
|
US5808056A
(en)
|
1995-10-31 |
1998-09-15 |
Merck & Co., Inc. |
Process for preparing substituted azetidinones
|
|
BR9612998B1
(pt)
|
1995-10-31 |
2010-03-23 |
|
2-azetidinonas substituÍdas com aÇécar éteis como agentes hipocolesterolÊmicos, composiÇço farmacÊutica e kit contendo as mesmas.
|
|
WO1997016424A1
(en)
|
1995-11-02 |
1997-05-09 |
Schering Corporation |
Process for preparing 1-(4-fluorophenyl)-3(r)-(3(s)-hydroxy-3-([phenyl or 4-fluorophenyl])-propyl)-4(s)-(4-hydroxyphenyl)-2-azetidinone
|
|
JP2000500155A
(ja)
|
1995-11-14 |
2000-01-11 |
クノール ファーマスーティカル カンパニー |
安定化された甲状腺ホルモン製剤及びその製法
|
|
US5925333A
(en)
|
1995-11-15 |
1999-07-20 |
Massachusetts Institute Of Technology |
Methods for modulation of lipid uptake
|
|
JPH09143156A
(ja)
|
1995-11-17 |
1997-06-03 |
Tanabe Seiyaku Co Ltd |
アセトキシアゼチジノン誘導体の製法及びその合成中間体
|
|
US5807578A
(en)
|
1995-11-22 |
1998-09-15 |
Lab Pharmaceutical Research International Inc. |
Fast-melt tablet and method of making same
|
|
US5807577A
(en)
|
1995-11-22 |
1998-09-15 |
Lab Pharmaceutical Research International Inc. |
Fast-melt tablet and method of making same
|
|
WO1997021676A1
(en)
|
1995-12-08 |
1997-06-19 |
Smithkline Beecham Plc |
Azetidinone compounds for the treatment of atherosclerosis
|
|
US6080767A
(en)
|
1996-01-02 |
2000-06-27 |
Aventis Pharmaceuticals Products Inc. |
Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
|
|
GB9600464D0
(en)
*
|
1996-01-09 |
1996-03-13 |
Smithkline Beecham Plc |
Novel method
|
|
US5847008A
(en)
|
1996-02-02 |
1998-12-08 |
Merck & Co., Inc. |
Method of treating diabetes and related disease states
|
|
US5859051A
(en)
|
1996-02-02 |
1999-01-12 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
WO1997028149A1
(en)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
|
GB9604242D0
(en)
|
1996-02-28 |
1996-05-01 |
Glaxo Wellcome Inc |
Chemical compounds
|
|
DE19608750A1
(de)
|
1996-03-06 |
1997-09-11 |
Durachemie Gmbh & Co Kg |
Verfahren zur Herstellung von Fenofibrat-Präparaten
|
|
IL117702A0
(en)
|
1996-03-28 |
1996-07-23 |
Tel Aviv Medical Center Resear |
Drug for hyperlipoproteinemia
|
|
GB9606805D0
(en)
|
1996-03-30 |
1996-06-05 |
Glaxo Wellcome Inc |
Medicaments
|
|
US5858409A
(en)
|
1996-04-17 |
1999-01-12 |
Fmc Corporation |
Hydrolyzed cellulose granulations for pharmaceuticals
|
|
EP0915843A1
(en)
|
1996-04-26 |
1999-05-19 |
Smithkline Beecham Plc |
Azetidinone derivatives for the treatment of atheroscleroses
|
|
US5843984A
(en)
|
1996-05-09 |
1998-12-01 |
Eli Lilly And Company |
Sulfated benzothiophene derivatives, methods of use and formulations containing same
|
|
US5886171A
(en)
|
1996-05-31 |
1999-03-23 |
Schering Corporation |
3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones
|
|
US5739321A
(en)
|
1996-05-31 |
1998-04-14 |
Schering Corporation |
3-hydroxy γ-lactone based enantionselective synthesis of azetidinones
|
|
US6245743B1
(en)
|
1996-06-05 |
2001-06-12 |
Cor Therapeutics, Inc. |
Inhibitors of factor Xa
|
|
GB9611947D0
(en)
|
1996-06-07 |
1996-08-07 |
Glaxo Group Ltd |
Medicaments
|
|
US5998421A
(en)
|
1996-06-12 |
1999-12-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Lipid metabolism ameliorants
|
|
US5965553A
(en)
|
1996-06-20 |
1999-10-12 |
Pfizer Inc. |
Squalene synthetase inhibitors
|
|
AU3667297A
(en)
|
1996-07-09 |
1998-02-02 |
Merck & Co., Inc. |
Therapy for combined hyperlipidemia
|
|
US6139873A
(en)
|
1996-07-10 |
2000-10-31 |
Cedars-Sinai Medical Center |
Combined pharmaceutical estrogen-androgen-progestin
|
|
US5883109A
(en)
|
1996-07-24 |
1999-03-16 |
Bristol-Myers Squibb Company |
Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
|
|
US5952003A
(en)
|
1996-08-01 |
1999-09-14 |
Novartis Corporation |
Terazosin capsules
|
|
AU4050797A
(en)
|
1996-08-02 |
1998-02-25 |
Ligand Pharmaceuticals Incorporated |
Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
|
|
US6057342A
(en)
|
1996-08-16 |
2000-05-02 |
Dupont Pharmaceutical Co. |
Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
|
|
US6235706B1
(en)
|
1996-09-18 |
2001-05-22 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardiovascular disease
|
|
US6251852B1
(en)
|
1996-09-18 |
2001-06-26 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardiovascular disease
|
|
US5972389A
(en)
|
1996-09-19 |
1999-10-26 |
Depomed, Inc. |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
|
|
US5959123A
(en)
|
1996-09-23 |
1999-09-28 |
Synphar Laboratories, Inc. |
3,4-Disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
|
|
HUP0000116A3
(en)
|
1996-10-01 |
2000-08-28 |
Stanford Res Inst Int |
Taste-masked microcapsule compositions and methods of manufacture
|
|
US6262047B1
(en)
|
1996-10-11 |
2001-07-17 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
|
US5756470A
(en)
|
1996-10-29 |
1998-05-26 |
Schering Corporation |
Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
SI0946185T2
(sl)
|
1996-11-27 |
2010-08-31 |
Aventis Pharma Inc |
Farmacevtski sestavek, ki obsega spojino z anti-Xa-aktivnostjo in antagonistično spojino za agregacijo ploščic
|
|
US6090839A
(en)
|
1996-12-23 |
2000-07-18 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
FR2758459B1
(fr)
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
|
FR2758461A1
(fr)
|
1997-01-17 |
1998-07-24 |
Pharma Pass |
Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
|
|
US6066653A
(en)
|
1997-01-17 |
2000-05-23 |
Bristol-Myers Squibb Co. |
Method of treating acid lipase deficiency diseases with an MTP inhibitor and cholesterol lowering drugs
|
|
CA2276467A1
(en)
|
1997-01-17 |
1998-07-23 |
Bristol-Myers Squibb Company |
Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs
|
|
WO1998043081A1
(en)
|
1997-03-26 |
1998-10-01 |
Ligand Pharmaceuticals Incorporated |
Treatment of gastrointestinal disease with ppar modulators
|
|
EP1003501B9
(en)
|
1997-04-02 |
2005-06-08 |
The Brigham And Women's Hospital, Inc. |
Use of an agent for lowering the risk of cardiovascular disease
|
|
US6024981A
(en)
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
|
DE19716120A1
(de)
|
1997-04-17 |
1998-10-22 |
Europ Lab Molekularbiolog |
Verwendung von cholesterinsenkenden Mitteln
|
|
AU735760B2
(en)
|
1997-04-24 |
2001-07-12 |
Merck Sharp & Dohme Limited |
Use of a NK-1 receptor antagonist and an SSRI for treating obesity
|
|
SK286392B6
(sk)
|
1997-05-14 |
2008-09-05 |
Atherogenics, Inc. |
Ester probukolu s kyselinou jantárovou a jeho použitie na inhibíciu expresie VCAM-1 a liečenie kardiovaskulárnych a zápalových ochorení
|
|
WO1998057545A1
(en)
*
|
1997-06-17 |
1998-12-23 |
Rutgers, The State University Of New Jersey |
Hypocholesterolemic compositions from bamboo shoots
|
|
US6423754B1
(en)
|
1997-06-18 |
2002-07-23 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with polyallylamine polymers
|
|
EP1023907B1
(en)
|
1997-07-24 |
2009-01-21 |
Astellas Pharma Inc. |
Medicinal compositions with cholesterol-lowering effect
|
|
DE69837610T2
(de)
|
1997-07-31 |
2008-01-03 |
Kos Life Sciences, Inc., Weston |
Manteltablette enthaltend nikotinsäure oder einen stoff, der zu nikotinsäure metabolisiert wird in verzögert freigesetzter form und einen hmg-coa reduktasehemmer im mantel zur sofortigen freisetzung
|
|
US20010006644A1
(en)
|
1997-07-31 |
2001-07-05 |
David J. Bova |
Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
|
|
WO1999007381A1
(en)
|
1997-08-11 |
1999-02-18 |
Weider Nutrition International, Inc. |
Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
|
|
US5886191A
(en)
|
1997-08-18 |
1999-03-23 |
Dupont Pharmaceuticals Company |
Amidinoindoles, amidinoazoles, and analogs thereof
|
|
US5869098A
(en)
|
1997-08-20 |
1999-02-09 |
Fuisz Technologies Ltd. |
Fast-dissolving comestible units formed under high-speed/high-pressure conditions
|
|
WO2001018210A1
(en)
|
1999-09-08 |
2001-03-15 |
Genentech, Inc. |
Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
|
|
US6180660B1
(en)
|
1997-08-26 |
2001-01-30 |
Merck & Co., Inc. |
Cholesterol-lowering therapy
|
|
CA2300165A1
(en)
|
1997-08-26 |
1999-03-04 |
Merck & Co., Inc. |
Cholesterol-lowering therapy
|
|
US6143885A
(en)
|
1997-08-27 |
2000-11-07 |
Merck & Co., Inc. |
Preparation of beta-methyl carbapenem intermediates
|
|
GT199800126A
(es)
|
1997-08-29 |
2000-01-29 |
|
Terapia de combinacion.
|
|
CA2303438A1
(en)
|
1997-09-09 |
1999-03-18 |
Bristol-Myers Squibb Pharma Company |
Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
|
|
AU8996698A
(en)
|
1997-09-10 |
1999-03-29 |
Ono Pharmaceutical Co. Ltd. |
Peroxisome proliferator-activated receptor controllers
|
|
GB2329334A
(en)
|
1997-09-18 |
1999-03-24 |
Reckitt & Colmann Prod Ltd |
Cholesterol-lowering agents
|
|
CA2214895C
(en)
|
1997-09-19 |
1999-04-20 |
Bernard Charles Sherman |
Improved pharmaceutical composition comprising fenofibrate
|
|
WO1999015520A1
(fr)
|
1997-09-19 |
1999-04-01 |
Ono Pharmaceutical Co., Ltd. |
Composes de benzene fusionnes ou non fusionnes
|
|
EP1017375A2
(en)
|
1997-09-24 |
2000-07-12 |
Nova Molecular, Inc. |
Methods for increasing apoe levels for the treatment of neurodegenerative disease
|
|
AU9426098A
(en)
|
1997-10-07 |
1999-04-27 |
Boehringer Ingelheim (Canada) Ltd. |
Azetidinone derivatives for the treatment of hcmv infections
|
|
IE970731A1
(en)
|
1997-10-07 |
2000-10-04 |
Fuisz Internat Ltd |
Product and method for the treatment of hyperlipidemia
|
|
US6147109A
(en)
|
1997-10-14 |
2000-11-14 |
The General Hospital Corporation |
Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
|
|
US6005102A
(en)
|
1997-10-15 |
1999-12-21 |
American Home Products Corporation |
Aryloxy-alkyl-dialkylamines
|
|
EA200000427A1
(ru)
|
1997-10-17 |
2001-02-26 |
Авентис Фармасьютикалз Продактс Инк. |
Терапевтические применения хинолиновых производных
|
|
WO1999020614A1
(en)
|
1998-05-27 |
1999-04-29 |
Dr. Reddy's Research Foundation |
Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
|
EP1027045A4
(en)
|
1997-10-31 |
2004-12-08 |
Arch Dev Corp |
METHODS AND COMPILATIONS FOR REGULATING S-ALPHA REDUCTASE ACTIVITY
|
|
US20030153541A1
(en)
*
|
1997-10-31 |
2003-08-14 |
Robert Dudley |
Novel anticholesterol compositions and method for using same
|
|
US6027747A
(en)
|
1997-11-11 |
2000-02-22 |
Terracol; Didier |
Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
|
|
AU1809499A
(en)
|
1997-12-10 |
1999-06-28 |
Awadhesh K. Mishra |
Self-emulsifying fenofibrate formulations
|
|
US5985936A
(en)
|
1997-12-18 |
1999-11-16 |
Forbes Medi-Tech, Inc. |
Method of preventing and delaying onset of Alzheimer's disease and composition therefor
|
|
US6008237A
(en)
|
1997-12-19 |
1999-12-28 |
Merck & Co., Inc. |
Arylthiazolidinedione derivatives
|
|
JP2002501887A
(ja)
|
1998-01-28 |
2002-01-22 |
ワーナー−ランバート・カンパニー |
アルツハイマー病の治療方法
|
|
AU1887999A
(en)
|
1998-01-29 |
1999-08-16 |
Dr. Reddy's Research Foundation |
Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
US6200995B1
(en)
|
1998-01-29 |
2001-03-13 |
Tularik Inc. |
PPAR-γ modulators
|
|
US6133001A
(en)
|
1998-02-23 |
2000-10-17 |
Schering Corporation |
Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-[3(S)-Hydroxy-3-(4-fluorophenyl)propyl)]-4(S)-(4 -hydroxyphenyl)-2-azetidinone
|
|
WO1999046232A1
(fr)
|
1998-03-10 |
1999-09-16 |
Ono Pharmaceutical Co., Ltd. |
Derives d'acide carboxylique et medicaments contenant ces derives comme principe actif
|
|
US6235311B1
(en)
|
1998-03-18 |
2001-05-22 |
Bristol-Myers Squibb Company |
Pharmaceutical composition containing a combination of a statin and aspirin and method
|
|
US6080778A
(en)
|
1998-03-23 |
2000-06-27 |
Children's Medical Center Corporation |
Methods for decreasing beta amyloid protein
|
|
US6180625B1
(en)
|
1998-03-24 |
2001-01-30 |
Novo Nordisk A/S |
Heterocyclic compounds regulating clotting
|
|
WO1999050255A2
(en)
|
1998-03-27 |
1999-10-07 |
Du Pont Pharmaceuticals Company |
Disubstituted pyrazolines and triazolines as factor xa inhibitors
|
|
AU3567299A
(en)
*
|
1998-04-17 |
1999-11-08 |
Medical Isotopes Inc. |
Phytosterol formulations to lower cholesterol absorption
|
|
EP1073643B1
(en)
|
1998-04-23 |
2004-12-29 |
Dr. Reddy's Laboratories Ltd. |
New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
RO120542B1
(ro)
|
1998-04-29 |
2006-03-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Derivaţi de beta-aminotetralină, ca liganzi pentru receptorul y5 al neuropeptidei y, utilizaţi în tratamentul obezităţii şi al altor tulburări
|
|
US6262042B1
(en)
|
1998-05-29 |
2001-07-17 |
Research Triangle Institute |
17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
|
|
FR2779347A1
(fr)
|
1998-06-05 |
1999-12-03 |
Arlette Guerry |
Procede de micronisation de substances medicamenteuses
|
|
JP2002518448A
(ja)
|
1998-06-24 |
2002-06-25 |
メルク エンド カムパニー インコーポレーテッド |
高血中コレステロールを治療する組成物および方法
|
|
JP2002518449A
(ja)
|
1998-06-24 |
2002-06-25 |
メルク エンド カムパニー インコーポレーテッド |
高血中コレステロールを治療する組成物および方法
|
|
US6099865A
(en)
|
1998-07-08 |
2000-08-08 |
Fmc Corporation |
Croscarmellose taste masking
|
|
FR2781222A1
(fr)
|
1998-07-17 |
2000-01-21 |
Lipha |
Composes cycliques utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procede de preparation
|
|
DE69911975T2
(de)
|
1998-07-31 |
2004-09-09 |
Novo Nordisk A/S |
In-vitro stimulation von beta zellen vermehrung
|
|
ES2255294T3
(es)
|
1998-08-07 |
2006-06-16 |
Chiron Corporation |
Derivados de isoxazol sustituidos como moduladores del receptor de estrogenos.
|
|
FR2783421B1
(fr)
|
1998-09-17 |
2000-11-24 |
Cll Pharma |
Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
|
|
US6147090A
(en)
|
1998-09-17 |
2000-11-14 |
Pfizer Inc. |
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
|
|
EP1117392B1
(en)
|
1998-09-30 |
2004-02-25 |
Warner-Lambert Company Llc |
Method for preventing or delaying catheter-based revascularization
|
|
US5919672A
(en)
|
1998-10-02 |
1999-07-06 |
Schering Corporation |
Resolution of trans-2-(alkoxycarbonylethyl)-lactams useful in the synthesis of 1-(4-fluoro-phenyl)-3(R)- (S)-hydroxy-3-(4-fluorophenyl)-propyl!-4(S)-(4-hydroxyphenyl)-2-azetidinone
|
|
WO2000023415A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
EP1123292A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
AU6190299A
(en)
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
|
EP1123297A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
WO2000023416A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
US6248781B1
(en)
|
1998-10-21 |
2001-06-19 |
Novo Nordisk A/S |
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
|
|
CA2253769C
(en)
|
1998-11-10 |
2000-09-26 |
Bernard Charles Sherman |
Pharmaceutical compositions comprising fenofibrate
|
|
US6472421B1
(en)
|
1998-11-13 |
2002-10-29 |
Nymox Corporation |
Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
|
|
EP1133699A1
(en)
|
1998-11-25 |
2001-09-19 |
Scios Inc. |
Prevention and treatment of amyloid-associated disorders
|
|
SA99191255B1
(ar)
|
1998-11-30 |
2006-11-25 |
جي دي سيرل اند كو |
مركبات سيليكوكسيب celecoxib
|
|
US6207822B1
(en)
|
1998-12-07 |
2001-03-27 |
Schering Corporation |
Process for the synthesis of azetidinones
|
|
DE69925862T2
(de)
|
1998-12-07 |
2006-05-04 |
Schering Corp. |
Verfahren zur herstellung von azetidinonen
|
|
US6277584B1
(en)
|
1998-12-16 |
2001-08-21 |
Dade Behring Inc. |
Method for calibrating a chemical analyzer with improved accuracy at low signal levels
|
|
DE19858789A1
(de)
|
1998-12-18 |
2000-06-21 |
Bayer Ag |
Kombination von Cerivastatin und Fibraten
|
|
JP2002532539A
(ja)
|
1998-12-18 |
2002-10-02 |
アボット・ラボラトリーズ |
脂質調節剤を含む新規な製剤
|
|
DE69904079T2
(de)
|
1998-12-23 |
2003-07-17 |
G.D. Searle Llc, Chicago |
Kombinationen von ileumgallensäuretransports inhibitoren und gallensäure sequestriermitteln für kardiovaskuläre indikationen
|
|
IL143949A0
(en)
|
1998-12-23 |
2002-04-21 |
Searle Llc |
Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
|
|
CA2356607A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle Llc |
Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
|
|
IL143946A0
(en)
|
1998-12-23 |
2002-04-21 |
Searle Llc |
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein for cardiovascular indications
|
|
PT1140185E
(pt)
|
1998-12-23 |
2003-10-31 |
Searle Llc |
Combinacoes de inibidores de proteina de transferencia de ester de colesterilo com agentes sequestrantes de acido biliar para indicacoes cardiovasculares
|
|
EP1340508A1
(en)
|
1998-12-23 |
2003-09-03 |
G.D. Searle LLC. |
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
|
|
WO2000038722A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle & Co. |
COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
|
|
MXPA01006467A
(es)
|
1998-12-23 |
2004-03-10 |
Searle Llc |
Combinaciones de inhibidores de trasnporte de acido biliar ileal y derivados de acido nicotinico para indicaciones cardiovasculares.
|
|
WO2000038725A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle Llc |
Combinations for cardiovascular indications
|
|
AR022204A1
(es)
|
1999-01-08 |
2002-09-04 |
Norgine Bv |
Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.
|
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
|
GB0000710D0
(en)
|
1999-02-06 |
2000-03-08 |
Zeneca Ltd |
Drug combination
|
|
AU2690600A
(en)
|
1999-02-24 |
2000-09-14 |
Fuji Chemical Industries, Ltd. |
2-mercaptocarboxylic acid derivatives
|
|
EP1036563A1
(en)
|
1999-03-08 |
2000-09-20 |
MERCK & CO. INC. |
Delayed-release oral formulation of dihydroxy open acid simvastatin and salts and esters thereof
|
|
AU2866400A
(en)
|
1999-03-08 |
2000-09-28 |
Merck & Co., Inc. |
Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors
|
|
JP2002538189A
(ja)
|
1999-03-10 |
2002-11-12 |
ジー．ディー．サール アンド カンパニー |
シクロオキシゲナーゼ−２インヒビターの投与方法と組成物
|
|
MXPA01009127A
(es)
|
1999-03-11 |
2003-07-14 |
Nuclear Receptor Res Ltd |
Ligandos novedosos de receptores nucleares, receptores activados por proliferacion de peroxisoma.
|
|
EP1175246A4
(en)
|
1999-03-19 |
2004-12-15 |
Brigham & Womens Hospital |
POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE OF TYPE III ENDOTHELIAL CELLS BY HMG-COA REDUCTASE INHIBITORS
|
|
HK1043936A1
(zh)
|
1999-03-31 |
2002-10-04 |
Abbott Laboratories |
含有脂調節劑的新的配方
|
|
EP1165141A2
(en)
|
1999-03-31 |
2002-01-02 |
Abbott Laboratories |
Novel formulations comprising lipid-regulating agents
|
|
HK1042115A1
(zh)
|
1999-04-05 |
2002-08-02 |
Merck Sharp & Dohme Corp. |
配製1-(4-氟苯)-3(r)-[3(s)-氟氧基-3-(4-氟苯)丙基)]-4(s)-(4-羥苯基)-2-azetidinone的立體定向微生物降低法
|
|
US6593078B1
(en)
|
1999-04-16 |
2003-07-15 |
Schering Corporation |
Use of azetidinone compounds
|
|
WO2000063161A1
(en)
|
1999-04-19 |
2000-10-26 |
Coelacanth Corporation |
Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
|
|
AU3958200A
(en)
|
1999-04-20 |
2000-11-02 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
WO2000063209A1
(en)
|
1999-04-20 |
2000-10-26 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
AU3957900A
(en)
|
1999-04-20 |
2000-11-02 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
AU3958000A
(en)
|
1999-04-20 |
2000-11-02 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
CA2270306C
(en)
|
1999-04-27 |
2000-09-26 |
Bernard Charles Sherman |
Pharmaceutical compositions comprising co-micronized fenofibrate
|
|
US6033656A
(en)
|
1999-05-04 |
2000-03-07 |
Sumitomo Chemical Company, Limited |
Method of preventing or alleviating mammalian obesity
|
|
AU3988099A
(en)
|
1999-05-13 |
2000-12-05 |
Geltex Pharmaceuticals, Inc. |
Combination therapy for treating hypercholesterolemia
|
|
CA2373681A1
(en)
|
1999-05-14 |
2000-11-23 |
Dennis I. Goldberg |
Pharmaceutical compositions for treating angina and/or anginal equivalents, and kit relating thereto
|
|
WO2000072829A1
(en)
|
1999-05-28 |
2000-12-07 |
Abbott Laboratories |
Novel formulations comprising lipid-regulating agents
|
|
US6465011B2
(en)
|
1999-05-29 |
2002-10-15 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
|
JP4618845B2
(ja)
|
1999-06-09 |
2011-01-26 |
杏林製薬株式会社 |
ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体
|
|
US6372251B2
(en)
|
1999-06-11 |
2002-04-16 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
|
GB9913782D0
(en)
|
1999-06-14 |
1999-08-11 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6207699B1
(en)
|
1999-06-18 |
2001-03-27 |
Richard Brian Rothman |
Pharmaceutical combinations for treating obesity and food craving
|
|
CA2376919C
(en)
|
1999-06-18 |
2008-11-04 |
Merck & Co., Inc. |
Arylthiazolidinedione and aryloxazolidinedione derivatives
|
|
JP2003502370A
(ja)
|
1999-06-18 |
2003-01-21 |
メルク エンド カムパニー インコーポレーテッド |
アリールチアゾリジンジオン誘導体およびアリールオキサゾリジンジオン誘導体
|
|
GB9914977D0
(en)
|
1999-06-25 |
1999-08-25 |
Glaxo Group Ltd |
Chemical compounds
|
|
ES2437103T3
(es)
|
1999-06-30 |
2014-01-08 |
Amgen Inc. |
Compuestos para la modulacion de la actividad de PPAR gamma
|
|
HRP20020090B1
(hr)
|
1999-08-03 |
2014-03-28 |
Icos Corporation |
FARMACEUTSKI PRIPRAVCI S Ăź-KARBOLINOM
|
|
EP1078632A1
(en)
|
1999-08-16 |
2001-02-28 |
Sanofi-Synthelabo |
Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
|
|
GB9919413D0
(en)
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
GB9919411D0
(en)
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
KR100738245B1
(ko)
|
1999-08-23 |
2007-07-12 |
교린 세이야꾸 가부시키 가이샤 |
치환된 벤질티아졸리딘-2,4-디온 유도체
|
|
CN1167691C
(zh)
|
1999-08-23 |
2004-09-22 |
杏林制药株式会社 |
取代的苄基噻唑烷-2,4-二酮衍生物
|
|
CA2382581C
(en)
|
1999-08-23 |
2007-06-12 |
Kyorin Pharmaceutical Co., Ltd. |
Substituted benzylthiazolidine-2,4-dione derivatives
|
|
ES2204684T3
(es)
|
1999-08-27 |
2004-05-01 |
Eli Lilly And Company |
Derivados de biaril-oxa(tia)zol y su uso como modulares de ppar.
|
|
JP2003508453A
(ja)
|
1999-08-31 |
2003-03-04 |
ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド |
アテローム性動脈硬化疾患の予防における診断的ツールとしての全身性炎症マーカー
|
|
EP1210345B1
(en)
|
1999-09-08 |
2004-03-03 |
Glaxo Group Limited |
Oxazole ppar antagonists
|
|
US6174665B1
(en)
|
1999-09-10 |
2001-01-16 |
Biex, Inc. |
Hormone replacement therapy monitoring
|
|
ATE316071T1
(de)
|
1999-09-17 |
2006-02-15 |
Kyorin Seiyaku Kk |
O-anisamid-derivate
|
|
US6585995B1
(en)
|
1999-09-21 |
2003-07-01 |
Hanson Stephen R |
Methods and compositions for treating platelet-related disorders
|
|
WO2001021647A2
(en)
|
1999-09-22 |
2001-03-29 |
Genset |
Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases
|
|
DE69923718T2
(de)
|
1999-09-24 |
2006-01-12 |
Kyorin Pharmaceutical Co., Ltd. |
Ppar-alpha und ppar-gamma-hemmer
|
|
WO2001022962A1
(en)
|
1999-09-30 |
2001-04-05 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
|
WO2001025225A2
(en)
|
1999-09-30 |
2001-04-12 |
Resolution Research Nederland B.V. |
Adducts of glycidylesters of alpha, alpha-branched carboxylic acids and acrylic acids and poly(ortho ester) as intermediate for their preparation
|
|
WO2001025226A1
(en)
|
1999-10-05 |
2001-04-12 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
|
CA2386750A1
(en)
|
1999-10-22 |
2001-05-03 |
Merck & Co. Inc. |
Pharmaceuticals for treating obesity
|
|
CA2389973A1
(en)
|
1999-11-04 |
2001-05-10 |
Andrx Corporation |
Method of treating amyloid beta precursor disorders
|
|
EP1243266A4
(en)
|
1999-11-11 |
2007-03-07 |
Kyorin Seiyaku Kk |
SOLID PREPARATIONS FOR ORAL ADMINISTRATION
|
|
EP1955703A1
(en)
|
1999-11-12 |
2008-08-13 |
Oncolytics Biotech Inc. |
Viruses for the treatment of cellular proliferative disorders
|
|
RU2256661C2
(ru)
|
1999-12-03 |
2005-07-20 |
Киото Фармасьютикал Индастриз, Лтд. |
Производные тетрагидроизохинолина и их соли и фармацевтическая композиция на их основе
|
|
ES2240209T3
(es)
|
1999-12-08 |
2005-10-16 |
Pharmacia Corporation |
Composiciones de eplerenona nanoparticulada.
|
|
WO2001045676A2
(en)
|
1999-12-20 |
2001-06-28 |
Schering Corporation |
Extended release oral dosage composition
|
|
US6248359B1
(en)
|
2000-01-05 |
2001-06-19 |
Laboratorios Phoenix U.S.A., Inc. |
Multi-tablet oxybutynin system for treating incontinence
|
|
US20010028895A1
(en)
|
2000-02-04 |
2001-10-11 |
Bisgaier Charles L. |
Methods of treating alzheimer's disease
|
|
JP2003523336A
(ja)
|
2000-02-18 |
2003-08-05 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病及び脂質障害のためのアリールオキシ酢酸
|
|
HK1048771A1
(zh)
|
2000-02-29 |
2003-04-17 |
Bristol-Myers Squibb Co. |
低劑量艾替開韋製劑及其應用
|
|
ES2263604T5
(es)
|
2000-04-10 |
2017-02-07 |
Nicholas John Wald |
Formulación para la Prevención de Enfermedad Cardiovascular
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
US20020013334A1
(en)
|
2000-06-15 |
2002-01-31 |
Robl Jeffrey A. |
HMG-CoA reductase inhibitors and method
|
|
US6191117B1
(en)
|
2000-07-10 |
2001-02-20 |
Walter E. Kozachuk |
Methods of producing weight loss and treatment of obesity
|
|
WO2002008188A1
(en)
|
2000-07-25 |
2002-01-31 |
Merck & Co., Inc. |
N-substituted indoles useful in the treatment of diabetes
|
|
US20020132855A1
(en)
|
2000-08-03 |
2002-09-19 |
Nelson Edward B. |
Use of acetaminophen to prevent and treat arteriosclerosis
|
|
DE10042447A1
(de)
|
2000-08-29 |
2002-03-28 |
Aventis Pharma Gmbh |
Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports
|
|
AU9287401A
(en)
|
2000-09-27 |
2002-04-08 |
Merck & Co Inc |
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
|
|
ES2287826T3
(es)
|
2000-12-20 |
2007-12-16 |
Schering Corp |
2-azetidinonas sustituidas con hidroxi utiles como agentes hipocolesterolemicos.
|
|
AU2002231688A1
(en)
|
2000-12-21 |
2002-07-01 |
Sanofi-Aventis Deutschland Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
|
AU2002216097B2
(en)
|
2000-12-21 |
2006-09-07 |
Sanofi-Aventis Deutschland Gmbh |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
|
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
|
AR032403A1
(es)
|
2001-01-26 |
2003-11-05 |
Schering Corp |
Combinaciones de inhibidor(es) de la absorcion de esterol con modificador(es) sanguineos para tratar cuadros vasculares
|
|
PT1363668E
(pt)
|
2001-01-26 |
2007-11-07 |
Schering Corp |
Combinaçoes de sequestrante(s) de ácidos biliares e inibidor(es) de absorção de esterol e tratamento de indicações vasculares
|
|
BRPI0206641B8
(pt)
*
|
2001-01-26 |
2021-05-25 |
Merck Sharp & Dohme |
uso de um inibidor da absorção de esteróis
|
|
NZ545332A
(en)
|
2001-01-26 |
2007-09-28 |
Schering Corp |
Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
|
|
CA2434488A1
(en)
|
2001-01-26 |
2002-08-01 |
Harry R. Davis |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
|
|
DK1353696T3
(da)
|
2001-01-26 |
2007-04-10 |
Schering Corp |
Kombinationer af peroxisomproliferatoraktiveret receptor (PPAR)-aktivator(er) og sterolabsorptionsinhibitor(er) og behandlinger til vaskulære indikationer
|
|
US7091230B2
(en)
|
2001-02-09 |
2006-08-15 |
Merck & Co., Inc. |
2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
|
|
DE10106787A1
(de)
|
2001-02-12 |
2002-08-22 |
Nanogate Gmbh |
Wasserfrei hydrolisierte Sol-Gel-Systeme
|
|
CA2438492A1
(en)
|
2001-02-15 |
2002-08-22 |
Pfizer Products Inc. |
Proliferative activator receptor (ppar) compounds
|
|
CA2438551A1
(en)
|
2001-02-15 |
2002-08-22 |
Pfizer Products Inc. |
Ppar agonists
|
|
EP1389114A2
(en)
|
2001-03-08 |
2004-02-18 |
Merck & Co., Inc. |
Antihypertensive agent and cholesterol absorption inhibitor combination therapy
|
|
WO2002081454A1
(en)
|
2001-04-09 |
2002-10-17 |
Dr. Reddy's Laboratories Ltd. |
Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
NZ531292A
(en)
|
2001-08-22 |
2005-08-26 |
Aventis Pharma Gmbh |
Combination products of aryl-subsituted propanolamine derivatives with other active ingredients and the use thereof
|
|
CN1655792A
(zh)
|
2001-08-22 |
2005-08-17 |
安万特医药德国有限公司 |
1,4－苯并硫杂䓬－1,1－二氧化物衍生物与其它活性成分的组合产物及其用途
|
|
WO2003039542A1
(en)
|
2001-10-17 |
2003-05-15 |
Merck & Co. Inc. |
Combination therapy for treating alzheimer's disease
|
|
AU2003217276A1
(en)
|
2002-02-28 |
2003-09-16 |
Eli Lilly And Company |
Method of treating atherosclerosis and hypercholesterolemia
|
|
AU2003225027A1
(en)
|
2002-04-16 |
2003-11-03 |
Merck And Co., Inc. |
Combination therapy using a ppar alpha/gamma agonist
|